In this episode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including the judicial activity surrounding Mifepristone, a medical abortion drug, and the recent announcement of Kaiser’s acquisition of Geisinger to launch Risant Health.
Podcast Tags: healthcare, healthcare news, health plans, life sciences, health policy, public health, mergers and acquisitions, FDA
Source Links:
- Texas judge halts FDA approval of abortion pill
- Supreme Court preserves access to key abortion drug as appeal proceeds
- Supreme Court Delays Decision on Abortion Pill, Preserving Access for Now
- Generic abortion pill manufacturer sues FDA in effort to preserve access
- Supreme Court Ensures, for Now, Broad Access to Abortion Pill
- 6 Ways the Mifepristone Rulings May Impact Future FDA Approvals
- Kaiser Permanente to Acquire Geisinger
- Kaiser Permanente and Geisinger come together to launch Risant Health
- Kaiser Permanente: Commitments and Impact
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor and Head of Public Health Sector
Ryan Hummel, Executive and Head of Provider Sector
Jen Burke, Healthcare Industry Strategist
Listen now
Speed to publication with GenAI: Done the right way
In the last three years, Generative AI (GenAI) has moved from novelty to expectation. Across industries, teams are being asked, whether explicitly or
Read moreInizio Ignite Sparks a New Era of Connected Advisory Solutions
Inizio Ignite brings together Research Partnership, Putnam, Vynamic, and STEM.
Read moreASH® 2025 roundtable: Turning hematology innovation into real world progress
Insights from ASH® 2025 on hematology innovation, CAR-T, bispecifics, diagnostics, and how connected strategy supports real-world adoption.
Read more